← Back to all trials
Not Yet Recruiting
NCT07756515
Chatbot Implementation In The Clinical Informed Consent Process
Conditions: Informed Consent
Sex: All
Ages: 18 Years – N/A
Healthy volunteers: No
Phase: NA
Enrollment: 100
Sponsor: M.D. Anderson Cancer Center
Location: UT MD Anderson Houston Texas
Summary
The purpose of this study is to determine the feasibility of implementing the chatbot "CoCo" in the IC process for research studies. We hypothesize that implementing a chatbot into the IC process will facilitate accurate information delivery and enhance participant comprehension and process satisfaction compared to traditional remote consent methods.
Eligibility Criteria
Inclusion Criteria:
* Ability to understand and willingness to provide informed consent.
* Age ≥18 years.
* Patients whose preferred language is English.
* Patients who are being considered for enrollment in selected clinical research studies.
Phase I will be initiated using the Clearinghouse protocol PA11-0852, a non-interventional biomarker study.
Exclusion Criteria:
N/A
Source: ClinicalTrials.gov (NCT07756515). StuddyBuddy aggregates publicly available trial information.
